Pharmaceutically acceptable salt of N-pyridazin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide
PK200901060A0Undetermined Publication Date: 2009-12-30PFIZER PROD INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200901060
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2009-12-02
- Publication Date
- 2009-12-30
Abstract
The present invention relates to pharmaceutically acceptable salt of a compound of Formula (I) Composition containing the compound; and uses of the compound in treating diseases or conditions associated with fatty acid amide hydrolase (FAHH) activity.
Need to check novelty before this filing date? Find Prior Art